To further reveal the mechanisms underlying the helper functions of NK cells in CD8+ T cell‐dependent anti‐PD‐L1 immunotherapy, we set out to determine tumor growth after anti‐PD‐L1 immunotherapy in mice with NK cell‐specific deletion of Prf1, Ifng, Tbx21, or Eomes. Here, CD8A is linked to neoplasm.